Skip to main content
MCUJF
OTC Life Sciences

Medicure Completes Enrollment in Pivotal Phase 3 Trial for Ultra-Rare PNPO Deficiency

Tom Rudovsky · Reported by ACCESS Newswire
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$2
Mkt Cap
$20.873M
52W Low
$0.436
52W High
$2
52W Position info
359% above low
Off High info
at 52W high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

MCUJF has more than doubled off its 52-week low of $0.436 on elevated volume (1.9× avg).

Summary

Medicure has completed enrollment in its MEND-PNPO Phase 3 trial, reaching the target of 10 patients for MC-1 in PNPO deficiency. This is a key milestone for an ultra-rare disease program with no approved therapy. The company holds FDA Rare Pediatric Disease, Orphan Drug, and Fast Track designations, and is eligible for a Priority Review Voucher upon NDA approval. With enrollment complete, focus shifts to patient follow-up and potential NDA submission. The stock is trading near its 52-week high, reflecting heightened investor attention on this catalyst.

At the time of this announcement, MCUJF was trading at $2.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $20.9M. The 52-week trading range was $0.44 to $2.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.


Price Chart

Share this article

Copied!

MCUJF - Latest Insights

MCUJF
Aug 19, 2026, 4:35 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.915
Real-time Price: $2.66 info
Change: +$1.74 (+190%) info
Market Cap: $27.708M info
MCUJF
May 21, 2026, 5:18 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.8039
Real-time Price: $2.66 info
Change: +$1.85 (+230%) info
Market Cap: $27.708M info
MCUJF
May 21, 2026, 5:18 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.8039
Real-time Price: $2.66 info
Change: +$1.85 (+230%) info
Market Cap: $27.708M info
MCUJF
May 21, 2026, 5:00 PM EDT
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $0.8039
Real-time Price: $2.66 info
Change: +$1.85 (+230%) info
Market Cap: $27.708M info
MCUJF
Apr 23, 2026, 6:26 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.9633
Real-time Price: $2.66 info
Change: +$1.69 (+176%) info
Market Cap: $27.708M info